tradingkey.logo

Catheter Precision Inc

VTAK

0.365USD

-0.065-15.12%
Fechamento 06/13, 16:00ETCotações atrasadas em 15 min
3.38MValor de mercado
PerdaP/L TTM

Catheter Precision Inc

0.365

-0.065-15.12%
Mais detalhes de Catheter Precision Inc Empresa
Catheter Precision, Inc. is a medical device company bringing solutions to market to improve the treatment of cardiac arrhythmias. The Company is focused on developing technology for electrophysiology (EP) procedures by collaborating with physicians and continuously advancing its products. The Company's two primary products are the View into Ventricular Onset System (VIVO System) and LockeT. The VIVO System is a non-invasive imaging system that offers three-dimensional (3D) cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure. Its product portfolio also includes the Amigo Remote Catheter System. It is developing technology for the treatment of acute decompensated heart failure.
Informações da empresa
Código da empresaVTAK
Nome da EmpresaCatheter Precision Inc
Data de listagemSep 27, 2018
Fundado em2018
CEOMr. David A. Jenkins
Número de funcionários22
Tipo de títulosOrdinary Share
Fim do ano fiscalSep 27
Endereço1670 Highway 160 West
CidadeFORT MILL
Bolsa de valoresNYSE American Consolidated
PaísUnited States of America
Código postal29708
Telefone19736912000
Sitehttps://www.ramed.com/
Código da empresaVTAK
Data de listagemSep 27, 2018
Fundado em2018
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. David A. Jenkins
Mr. David A. Jenkins
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
194.18K
--
Mr. Martin J. Colombatto
Mr. Martin J. Colombatto
Independent Director
Independent Director
40.00
--
Mr. Philip J. Anderson
Mr. Philip J. Anderson
Chief Financial Officer, Secretary
Chief Financial Officer, Secretary
--
--
Mr. James J. Caruso
Mr. James J. Caruso
Independent Director
Independent Director
--
--
Mr. Tony Dacosta
Mr. Tony Dacosta
Investor Relations
Investor Relations
--
--
Andrew Arno ,
Andrew Arno ,
Independent Director
Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. David A. Jenkins
Mr. David A. Jenkins
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
194.18K
--
Mr. Martin J. Colombatto
Mr. Martin J. Colombatto
Independent Director
Independent Director
40.00
--
Mr. Philip J. Anderson
Mr. Philip J. Anderson
Chief Financial Officer, Secretary
Chief Financial Officer, Secretary
--
--
Mr. James J. Caruso
Mr. James J. Caruso
Independent Director
Independent Director
--
--
Mr. Tony Dacosta
Mr. Tony Dacosta
Investor Relations
Investor Relations
--
--
Andrew Arno ,
Andrew Arno ,
Independent Director
Independent Director
--
--
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de abr
Moeda: USDAtualizado em: dom, 6 de abr
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q2
FY2023Q1
FY2022
FY2021
FY2020
FY2019
Sem dados
Por RegiãoUSD
Nome
Receita
Proporção
United States
278.00K
66.19%
All other countries
142.00K
33.81%
Por Empresa
Por Região
Sem dados
Distribuição de ações
Atualizado em: seg, 2 de jun
Atualizado em: seg, 2 de jun
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Jenkins Family Charitable Institute
5.56%
Armistice Capital LLC
1.99%
Jenkins (David A)
1.54%
Warberg Asset Management LLC
1.43%
FatBoy Capital LP
0.56%
Other
88.91%
Investidores
Investidores
Proporção
Jenkins Family Charitable Institute
5.56%
Armistice Capital LLC
1.99%
Jenkins (David A)
1.54%
Warberg Asset Management LLC
1.43%
FatBoy Capital LP
0.56%
Other
88.91%
Tipos de investidores
Investidores
Proporção
Corporation
6.12%
Hedge Fund
3.87%
Individual Investor
1.87%
Investment Advisor/Hedge Fund
0.43%
Venture Capital
0.35%
Other
87.35%
Participação acionária institucional
Atualizado em: ter, 4 de mar
Atualizado em: ter, 4 de mar
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q1
34
1.36M
13.26%
-1.65K
2024Q4
37
1.12M
13.97%
-215.80K
2024Q3
45
563.38K
38.63%
+376.14K
2024Q2
46
202.02K
23.51%
+5.34K
2024Q1
50
211.28K
24.77%
+47.42K
2023Q4
52
169.47K
25.10%
+5.69K
2023Q3
56
180.73K
31.24%
+30.19K
2023Q2
57
168.19K
29.83%
+996.00
2023Q1
61
185.84K
35.83%
+171.62K
2022Q4
62
8.84K
7.57%
+1.23K
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Jenkins Family Charitable Institute
500.23K
5.4%
--
--
Dec 31, 2024
Armistice Capital LLC
129.16K
1.39%
-444.39K
-77.48%
Dec 31, 2024
Jenkins (David A)
32.99K
0.36%
--
--
Jan 29, 2025
Warberg Asset Management LLC
310.16K
3.35%
+243.16K
+362.93%
Dec 31, 2024
FatBoy Capital LP
70.97K
0.77%
--
--
Jan 29, 2025
Geode Capital Management, L.L.C.
7.54K
0.08%
+6.40K
+563.73%
Feb 28, 2025
XTX Markets LLC
23.88K
0.26%
+23.88K
--
Dec 31, 2024
Caruso (James Joseph)
178.00
0%
--
--
Nov 18, 2024
Ver Mais
ETFs Relacionados
Nome
Proporção
Sem dados
Dividendo
Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Jul 03, 2024
Merger
10<1
Jul 03, 2024
Merger
10<1
Jul 03, 2024
Merger
10<1
Jul 03, 2024
Merger
10<1
Sep 21, 2022
Merger
50<1
Sep 21, 2022
Merger
50<1
Data
Tipo
Proporção
Jul 03, 2024
Merger
10<1
Jul 03, 2024
Merger
10<1
Jul 03, 2024
Merger
10<1
Jul 03, 2024
Merger
10<1
Sep 21, 2022
Merger
50<1
Sep 21, 2022
Merger
50<1
Sep 21, 2022
Merger
50<1
Sep 21, 2022
Merger
50<1
Nov 16, 2020
Merger
25<1
Nov 16, 2020
Merger
25<1
Ver Mais
KeyAI